Carole S. Ben-Maimon
2011 - Impax Laboratories
In 2011, Carole S. Ben-Maimon earned a total compensation of $1.5M as President, Global Pharmaceuticals division at Impax Laboratories.
Compensation breakdown
| Bonus | $37,500 |
|---|---|
| Non-Equity Incentive Plan | $142,159 |
| Option Awards | $708,008 |
| Salary | $142,808 |
| Stock Awards | $454,320 |
| Total | $1,484,795 |
Ben-Maimon received $708K in option awards, accounting for 48% of the total pay in 2011.
Ben-Maimon also received $37.5K in bonus, $142.2K in non-equity incentive plan, $142.8K in salary and $454.3K in stock awards.
Rankings
In 2011, Carole S. Ben-Maimon's compensation ranked 4,245th out of 10,747 executives tracked by ExecPay. In other words, Ben-Maimon earned more than 60.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,245 out of 10,747 | 61st |
Division Manufacturing | 1,504 out of 3,960 | 62nd |
Major group Chemicals And Allied Products | 307 out of 1,038 | 70th |
Industry group Drugs | 180 out of 786 | 77th |
Industry Pharmaceutical Preparations | 141 out of 571 | 75th |
Source: SEC filing on April 15, 2014.
Ben-Maimon's colleagues
We found three more compensation records of executives who worked with Carole S. Ben-Maimon at Impax Laboratories in 2011.